OPKO and Pfizer Enter into Global Agreement for OPKO’s Long-Acting Human Growth Hormone (hGH-CTP)Global Agreement • December 15th, 2014 • Opko Health, Inc. • Pharmaceutical preparations
• hGH-CTP has potential to reduce dosing frequency of human growth hormone to single weekly injection from current standard of daily injection
